論文

査読有り 最終著者 責任著者 国際誌
2019年11月22日

2-Methylthio Conversion of N6-Isopentenyladenosine in Mitochondrial tRNAs by CDK5RAP1 Promotes the Maintenance of Glioma-Initiating Cells.

iScience
  • Takahiro Yamamoto
  • ,
  • Atsushi Fujimura
  • ,
  • Fan-Yan Wei
  • ,
  • Naoki Shinojima
  • ,
  • Jun-Ichiro Kuroda
  • ,
  • Akitake Mukasa
  • ,
  • Kazuhito Tomizawa

21
開始ページ
42
終了ページ
56
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1016/j.isci.2019.10.012

2-Methylthio-N6-isopentenyl modification of adenosine (ms2i6A) is an evolutionally conserved modification found in mitochondrial (mt)-tRNAs. Cdk5 regulatory subunit-associated protein 1 (CDK5RAP1) specifically converts N6-isopentenyladenosine (i6A) to ms2i6A at position A37 of four mt-DNA-encoded tRNAs, and the modification regulates efficient mitochondrial translation and energy metabolism in mammals. Here, we report that the ms2 conversion mediated by CDK5RAP1 in mt-tRNAs is required to sustain glioma-initiating cell (GIC)-related traits. CDK5RAP1 maintained the self-renewal capacity, undifferentiated state, and tumorigenic potential of GICs. This regulation was not related to the translational control of mt-proteins. CDK5RAP1 abrogated the antitumor effect of i6A by converting i6A to ms2i6A and protected GICs from excessive autophagy triggered by i6A. The elevated activity of CDK5RAP1 contributed to the amelioration of the tumor-suppressive effect of i6A and promoted GIC maintenance. This work demonstrates that CDK5RAP1 is crucial for the detoxification of endogenous i6A and that GICs readily utilize this mechanism for survival.

リンク情報
DOI
https://doi.org/10.1016/j.isci.2019.10.012
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/31654853
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820277
ID情報
  • DOI : 10.1016/j.isci.2019.10.012
  • PubMed ID : 31654853
  • PubMed Central 記事ID : PMC6820277

エクスポート
BibTeX RIS